查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2003217

動物生長促效劑市場：2026-2032年全球市場預測（依產品類型、目標動物、劑型、給藥途徑、應用及通路分類）

Animal Growth Promoters Market by Product Type, Animal Type, Form, Mode Of Administration, Application, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，動物生長促效劑市場價值將達到 179.7 億美元，到 2026 年將成長至 193.1 億美元，到 2032 年將達到 325.7 億美元，複合年成長率為 8.86%。

主要市場統計數據
基準年 2025 179.7億美元
預計年份：2026年 193.1億美元
預測年份 2032 325.7億美元
複合年成長率 (%) 8.86%

我們為決策者提供清晰權威的指南，幫助他們在監管壓力、消費者期望和商業現實的框架內定位動物生長促進劑。

動物生長促進劑處於農業創新、動物健康管理和不斷變化的社會期望的交匯點。這些物質和生技藥品傳統上用於提高飼料轉換率、加快生長速度和降低疾病發生率，但如今正面臨日益嚴格的監管審查和消費者偏好的轉變。近年來，為了實現永續的生產力和市場認可，行業相關人員不得不重新評估產品系列、投資重點和供應鏈韌性。

這是監管、科學和供應鏈韌性的關鍵轉折點，重塑了整個產業的產品開發和商業策略。

近年來，動物生長促進劑的研發、監管和應用在整個生產系統中發生了變革性變化。首先，監理環境趨於謹慎，政策制定者越來越重視公共衛生和環境因素。這一趨勢促使企業加快非抗生素替代品的創新，並加大對完善的安全性和殘留資料包裝的投入。其次，飼料原料和活性成分供應鏈的中斷凸顯了供應鏈的脆弱性，促使企業更加重視在地採購、配方柔軟性和多供應商策略，使供應鏈韌性成為一項策略重點。

2025 年關稅措施如何重新調整了整個價值鏈中全球採購重點、營運合規負擔和本地製造的策略獎勵。

美國於2025年實施並提高關稅，對整個全球動物生長促進劑供應鏈產生了連鎖反應，促使製造商、經銷商和生產商調整其採購、定價和庫存管理策略。出口商和進口商重組了與供應商的關係，以降低關稅風險。這加速了企業向替代採購市場的多元化，並活性化了關於國內生產和關鍵原料近岸外包的討論。這些調整不僅僅是商業性應對措施；它們也影響了產品系列決策，因為企業需要評估哪些產品在新成本結構下具有商業性可行性，哪些產品需要修改配方或進行在地化生產。

透過對產品類型、物種特定需求、應用狀態、配方、給藥途徑和通路進行全面細分，確保策略清晰性。

深入的產品細分有助於在整個動物生長促效劑領域內，針對產品開發、商業性實施和監管規劃進行更精細的策略思考。依產品類型分類，每種產品類別都有獨特的商業和監管考量，包括Aminoglycosides、大環內酯類、青黴素類和四環黴素等抗生素；寡果醣、植酸酶和蛋白酶等酶；精油、半乳寡糖、黃體素、黃體素和生長激素等荷爾蒙；離子載體；香辛料、雙叉桿菌和香料等植物來源成分；以及以商業性組為中心的益生元，例如寡果糖、低聚半乳糖和甘露寡糖，以及以芽孢桿菌屬、通訊協定和乳桿菌屬為代表的益生菌。每個產品系列都有其獨特的證據要求、給藥方案以及獸醫和生產者認可的途徑。

主要全球區域在產品採用、監管合規路徑和商業策略方面存在細微的區域差異。

區域趨勢持續對動物生長促進劑的使用、監管方式以及商業性機會的發展產生重大影響。在美洲，政策方針和消費者需求共同推動創新和監管，尤其注重負責任的使用、可追溯性以及開發符合出口要求的替代品。該地區龐大且一體化的生產體係正在提升效率並促進技術應用，而貿易政策趨勢則影響著籌資策略和製造地的選址。

結合了傳統監管應對力、專業生物創新和合作市場進入模式的競爭格局正在塑造該領域未來的領導地位。

動物生長促進劑市場的競爭格局呈現出多元化的特點：既有擁有豐富監管經驗的成熟企業，也有專注於生物來源替代品的利基專家，還有利用微生物組科學和精準營養技術的新興創新者。成熟企業受益於規模經濟、完善的監管文件和成熟的分銷網路，這些優勢有助於其獲得廣泛的市場准入，並與一體化生產商和飼料製造商保持持續合作。同時，專注於酵素製劑、植物來源成分、益生元和益生菌的專業公司正利用其獨特的功效特性以及與畜牧管理目標的更緊密契合，透過與飼料整合商和獸醫服務機構合作，加速產品的推廣應用。

產業領導者現在可以採取具有重大影響的策略行動，以確保供應彈性、監管準備和差異化的商業性價值提案。

產業領導者應優先考慮一系列切實可行的舉措，以平衡短期韌性和長期差異化優勢。首先，他們應加快對替代技術的投資，以減少對傳統抗生素的依賴，並透過結合可靠的療效研究和實地試驗，贏得獸醫和生產者的信任。其次，他們應透過供應商多元化、評估關鍵原料的近岸生產方案以及實施能夠最大限度降低關稅和貿易風險的庫存和物流措施，來強化供應鏈策略。

採用嚴謹的混合方法研究途徑，結合專家訪談、監管分析和證據整合，得出可操作的產業見解。

本執行摘要的研究是基於多方面的證據，以確保分析的全面性和平衡性。關鍵的定性資料包括對價值鏈各環節專家的訪談，涵蓋製藥科學家、監管專家、銷售經理、獸醫和分銷合作夥伴。這些訪談為產品功效、註冊流程、市場推廣趨勢和分銷管道經濟效益提供了切實可行的觀點。二級資訊來源包括同行評審文獻、監管指導文件和技術白皮書，這些資料闡述了與動物生長促進相關的安全性、作用機制和新興技術。

策略概述重點闡述了科學進步、監管變化和供應鏈敏捷性如何決定該領域的競爭優勢。

總體而言，在不斷變化的監管環境、科學創新以及商業性和消費者期望的驅動下，動物生長促進劑市場正經歷著有意識的變革時期。生物基性能增強替代品有望提高營養利用效率和增強抗病能力，且不會引起公共衛生問題，因此擴大被拿來與傳統的生物來源生長促進劑進行比較。同時，貿易政策和關稅措施的變化也凸顯了供應鏈彈性和在地化生產方案的戰略重要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 動物生長促效劑市場：依產品類型分類

  • 抗生素
    • Aminoglycosides抗生素
    • 大環內酯類
    • 青黴素
    • 四環黴素
  • 酵素
    • 碳水化合物消化酶
    • 植酸酶
    • 蛋白酶
  • 荷爾蒙
    • 雄激素
    • 雌激素
    • 孕酮
    • 生長激素
  • 離子載體
  • 植物成分
    • 精油
    • 草藥萃取物
    • 香辛料
  • 益生元
    • 果寡糖
    • 半乳寡糖
    • 甘露聚醣
  • 益生菌
    • 芽孢桿菌
    • 雙歧桿菌
    • 乳酸桿菌

第9章 動物生長促效劑市場：依動物類型分類

  • 水生動物
  • 牛
  • 家禽
  • 豬

第10章：動物生長促效劑市場：依劑型分類

  • 顆粒
  • 液體
  • 顆粒
  • 粉末

第11章：以給藥方式分類的動物生長促效劑市場

  • 飼料添加劑
  • 注射藥物
  • 飲用水添加物

第12章 動物生長促效劑市場：依應用領域分類

  • 疾病預防
  • 促進生長
  • 選育

第13章 動物生長促效劑市場：依通路分類

  • 線上
  • 離線

第14章 動物生長促效劑市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 動物生長促效劑市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 動物生長促效劑市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國動物生長促效劑市場

第18章：中國動物生長促效劑市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Alltech, Inc.
  • Anpario plc
  • Archer Daniels Midland Company
  • Bayer AG
  • Biomin Holding GmbH
  • Boehringer Ingelheim Animal Health USA Inc.
  • Cargill, Incorporated
  • Ceva Sante Animale
  • Chr. Hansen Holding A/S
  • DSM-Firmenich AG
  • Elanco Animal Health Incorporated
  • Hubbard Feeds, Inc.
  • Kemin Industries, Inc.
  • Kent Nutrition Group, Inc.
  • Lallemand Animal Nutrition
  • Merck & Co., Inc.
  • Nutreco NV
  • Phibro Animal Health Corporation
  • Purina Animal Nutrition LLC
  • Vetoquinol SA
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-C803CE17101F

The Animal Growth Promoters Market was valued at USD 17.97 billion in 2025 and is projected to grow to USD 19.31 billion in 2026, with a CAGR of 8.86%, reaching USD 32.57 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 17.97 billion
Estimated Year [2026] USD 19.31 billion
Forecast Year [2032] USD 32.57 billion
CAGR (%) 8.86%

A clear and authoritative orientation that frames animal growth promoters within regulatory pressures, consumer expectations, and operational realities for decision-makers

Animal growth promoters sit at the intersection of agricultural innovation, animal health management, and evolving public expectations. Historically deployed to improve feed efficiency, accelerate growth rates, and reduce disease incidence, these substances and biologicals have become subject to heightened regulatory scrutiny and shifting consumer preferences. Over recent years, industry actors have been compelled to reassess product portfolios, investment priorities, and supply chain resilience as pathways to sustainable productivity and market acceptance.

The landscape encompasses a diverse set of active interventions, from synthetic compounds to biologically derived feed supplements, each bringing distinct efficacy profiles, administration modes, and regulatory pathways. Practitioners must weigh efficacy against safety, residue concerns, and long-term impacts such as antimicrobial resistance. At the same time, alternative approaches like enzyme supplementation, phytogenic additives, prebiotics, and precision nutrition are gaining attention for their ability to support performance while aligning with consumer demands for reduced antibiotic dependence.

Consequently, strategic planning for product development, commercialisation, and market access requires an integrated understanding of science, regulatory trends, stakeholder expectations, and distribution dynamics. By considering these dimensions together, organisations can position offerings that meet producer needs for performance while addressing public health and sustainability objectives, thereby creating durable competitive advantages in a complex operating environment.

Critical inflection points in regulation, science, and supply chain resilience that are reshaping product development and commercial strategies across the sector

Recent years have produced transformative shifts that are redefining how animal growth promoters are developed, regulated, and adopted across production systems. First, regulatory landscapes have moved toward greater precaution, with policymakers increasingly prioritising public health outcomes and environmental considerations; this trend has forced companies to accelerate innovation in non-antibiotic alternatives and to invest in robust safety and residue data packages. Second, supply chain resilience has become a strategic priority, as disruptions in feed ingredients and active materials have highlighted vulnerabilities and driven interest in local sourcing, formulation flexibility, and multi-supplier strategies.

Third, scientific advances in microbiome research and enzyme technologies are enabling more targeted interventions that improve nutrient utilisation and immune function without relying on traditional antibiotic growth promoters. These innovations are complemented by improved diagnostics and data analytics, which permit precision dosing and performance tracking at the farm level. Fourth, buyer and consumer expectations have matured; transparency in production practices and verifiable claims about animal welfare and product safety are now central to commercial acceptance in many value chains.

Taken together, these shifts are prompting a reconfiguration of R&D priorities, commercial strategies, and partnership models. Firms that integrate regulatory foresight, scientific differentiation, and supply chain adaptability into their strategic plans are better positioned to capture opportunities amid ongoing transformation, while those that delay adaptation may face increasing market and reputational risks.

How 2025 tariff actions recalibrated global sourcing priorities, operational compliance burdens, and strategic incentives for local manufacturing across the value chain

The introduction and escalation of tariffs by the United States in 2025 created a ripple effect across global supply chains that support animal growth promoters, prompting manufacturers, distributors, and producers to adjust sourcing, pricing structures, and inventory practices. Exporters and importers recalibrated supplier relationships to mitigate tariff exposure, which accelerated diversification toward alternative sourcing markets and stimulated conversations about on-shore manufacturing and near-shoring for critical inputs. These adaptations were not solely commercial; they also influenced portfolio decisions as companies evaluated which products remained commercially viable under new cost structures and which required reformulation or localisation.

In addition, tariff-induced friction increased the administrative burden for cross-border transactions, necessitating more robust customs compliance capabilities and contract renegotiations. This operational complexity was felt most strongly by smaller producers and suppliers with limited capacity to absorb added costs or to reconfigure supply chains rapidly. As a result, certain distribution channels and product formats that depend on imported intermediates experienced slower turnover and required alternative commercial tactics, such as longer lead times and consolidated shipments.

At the same time, policy responses from trade partners and domestic stakeholders included incentives and support measures aimed at bolstering local manufacturing capacity and reducing import dependency. These policy shifts encouraged investment into formulation technologies and manufacturing scale-up in target geographies. In sum, the cumulative impact of tariffs in 2025 reinforced the strategic importance of supply chain agility, regulatory compliance, and commercial flexibility for organisations operating within the animal growth promoter ecosystem.

Comprehensive segmentation insights that align product types, species-specific needs, application contexts, formulations, administration routes, and distribution pathways for strategic clarity

Insightful segmentation enables more precise strategic thinking about product development, commercial execution, and regulatory planning across the animal growth promoter domain. When products are considered by type-covering antibiotics such as aminoglycosides, macrolides, penicillins, and tetracyclines; enzymes including carbohydrase, phytase, and protease; hormones spanning androgens, estrogens, progesterones, and somatotropins; ionophores; phytogenics comprising essential oils, herbal extracts and spices; and microbiome-focused options such as prebiotics like fructo oligosaccharides, galacto oligosaccharides, and mannan oligosaccharides alongside probiotics exemplified by Bacillus, Bifidobacterium and Lactobacillus-distinct commercial and regulatory considerations emerge. Each product family implies unique evidence requirements, administration protocols, and pathways to acceptance among veterinarians and producers.

Equally important is differentiation by animal type, where interventions for aquatic animals, cattle, poultry and swine follow divergent performance expectations and regulatory frameworks. Application context further modifies strategic priorities: disease prevention, growth promotion, and reproduction each call for specific efficacy data, safety monitoring, and dosing strategies. Form selection-granules, liquid, pellets and powder-affects feed integration, stability, and on-farm handling preferences, while mode of administration through feed additives, injectables or water additives influences compliance, labor requirements, and cost structures.

Finally, distribution dynamics matter: direct sales, distributors, online retail platforms and veterinary hospitals each offer different routes to market, service requirements, and margin expectations. Integrating these segmentation dimensions enables sharper targeting of product design, registration planning, and go-to-market approaches, thereby increasing the likelihood of adoption and commercial success in distinct subsegments of the industry.

Regional dynamics and policy nuances that determine product adoption, regulatory compliance pathways, and commercial strategies across key global territories

Regional dynamics continue to exert significant influence on the evolution of animal growth promoter use, regulatory approaches, and commercial opportunities. In the Americas, policy approaches and consumer demands have driven both innovation and scrutiny, with a strong emphasis on responsible use, traceability, and the development of alternatives that meet export requirements. This region's large and integrated production systems have incentivised efficiency gains and technological adoption, while trade policy developments have influenced sourcing strategies and manufacturing footprints.

Across Europe, the Middle East and Africa, regulatory frameworks and market structures are heterogeneous, resulting in varied adoption patterns. European jurisdictions tend to apply stringent approval processes and to prioritise antimicrobial stewardship, which has accelerated uptake of non-antibiotic solutions and generated rigorous evidence expectations. Markets in the Middle East and Africa present diverse regulatory environments and demand profiles that create both challenges and niche opportunities for tailored products and distribution models.

In the Asia-Pacific region, rapid intensification of livestock and aquaculture production, coupled with evolving regulatory standards and strong consumer markets, has driven substantial demand for performance-enhancing and disease-management tools. Local innovation and regional manufacturing capacity have expanded in response to these dynamics, while fluctuating trade policies and input availability continue to shape commercial strategies. Understanding these regional nuances is essential for prioritising investment, tailoring regulatory dossiers, and designing distribution and marketing tactics that reflect local producer realities.

Competitive dynamics that blend legacy regulatory strength, specialist biological innovation, and collaborative go-to-market models shaping future leadership in the sector

The competitive landscape of animal growth promoters is characterised by a mix of legacy players with deep regulatory experience, niche specialists focused on biologically derived alternatives, and emerging innovators leveraging microbiome science and precision nutrition. Established firms benefit from scale, regulatory dossiers, and entrenched distribution networks, which facilitate broad market access and ongoing engagement with integrated producers and feed manufacturers. At the same time, specialist companies that concentrate on enzymes, phytogenics, prebiotics, and probiotics are capitalising on differentiated efficacy profiles and stronger alignment with stewardship objectives, often partnering with feed integrators and veterinary services to accelerate adoption.

Innovation is increasingly collaborative, with cross-sector partnerships between nutrition companies, biotechnology firms, and channel partners that can combine formulation expertise with deep customer insights. These partnerships support faster route-to-market for combinations of products and enable more credible evidence generation in real-world production settings. Additionally, manufacturing footprint and supply chain reliability remain strategic differentiators; firms that can assure consistent quality and timely delivery of active ingredients and finished formulations maintain a competitive edge, particularly when trade barriers or raw material volatility are present.

Finally, corporate strategies vary from deepening investments in regulatory science to pursuing targeted acquisitions that broaden portfolios in high-growth product categories. For decision-makers, identifying the right mix of internal R&D, external partnerships, and channel development will determine the capacity to convert scientific advantage into commercial performance while meeting heightened expectations from regulators and end consumers.

High-impact strategic actions that industry leaders can implement now to secure supply resilience, regulatory readiness, and differentiated commercial value propositions

Industry leaders should prioritise a set of actionable initiatives that balance near-term resilience with long-term differentiation. First, accelerate investment in alternative technologies that reduce reliance on traditional antibiotics, pairing robust efficacy studies with real-world trials to build credibility among veterinarians and producers. Second, strengthen supply chain strategies by diversifying suppliers, evaluating near-shore manufacturing options for critical inputs, and instituting inventory and logistics practices that minimise tariff and trade risk exposure.

Third, invest in regulatory intelligence and preemptive engagement with authorities to streamline approvals and to ensure that product claims are defensible across jurisdictions. Fourth, deepen partnerships with feed integrators, veterinary service providers and digital agriculture platforms to create bundled solutions that combine products with advisory services and performance monitoring. These integrated offerings can accelerate adoption by reducing on-farm complexity and by delivering measurable outcomes.

Fifth, enhance transparency and certification pathways that respond to consumer and buyer expectations about responsible use and animal welfare, using validated protocols to substantiate claims. Sixth, embed advanced analytics and on-farm diagnostics into commercial propositions to enable precision dosing and to demonstrate value at the farm level. Executed together, these actions will position organisations to manage regulatory headwinds, to capitalise on scientific progress, and to meet evolving stakeholder expectations in a contested yet opportunity-rich environment.

A rigorous mixed-methods research approach combining expert interviews, regulatory analysis, and evidence synthesis to produce actionable industry insights

The research underpinning this executive summary combines multiple evidence streams to ensure comprehensive and balanced analysis. Primary qualitative inputs included interviews with subject matter experts across the value chain, encompassing formulation scientists, regulatory specialists, commercial leaders, veterinarians, and distribution partners. These conversations provided practical perspectives on product efficacy, registration pathways, adoption dynamics, and channel economics. Secondary sources encompassed peer-reviewed literature, regulatory agency guidance documents, and technical white papers that elucidate safety profiles, mechanisms of action, and emerging technologies relevant to animal growth promotion.

Analytical methods integrated thematic synthesis of qualitative insights with systematic review of regulatory contexts and trade policy developments. Attention was given to triangulating findings from different geographies to identify consistent patterns and region-specific divergences. The approach emphasised transparency in assumptions, careful differentiation between evidence levels across product classes, and explicit consideration of operational and commercial constraints that influence adoption. Throughout, the methodology sought to balance scientific rigor with practical relevance for decision-makers focused on portfolio strategy, regulatory planning, and go-to-market execution.

A strategic closing synthesis highlighting how scientific advancement, regulatory shifts, and supply chain agility will determine competitive advantage in the sector

In aggregate, the animal growth promoter landscape is undergoing a period of purposeful transition driven by regulatory evolution, scientific innovation, and shifting commercial and consumer expectations. Traditional antibiotic-based growth promotion is increasingly juxtaposed with biologically derived and performance-enhancing alternatives that promise improved nutrient utilisation and disease resilience without the same public health concerns. Concurrently, trade policy shifts and tariff actions have underscored the strategic importance of supply chain agility and local manufacturing options.

For stakeholders, the path forward involves integrating scientific differentiation with robust regulatory strategies and channel partnerships that reduce barriers to adoption at the farm level. Organisations that move decisively to invest in validated alternatives, to secure diversified supply chains, and to offer bundled solutions that combine product, advisory services, and analytics will be better positioned to capture commercial opportunities while meeting heightened expectations for stewardship and transparency. In contrast, firms that rely solely on legacy approaches without adapting to emerging regulatory and market realities are likely to encounter increasing operational and reputational challenges. The future of the sector will reward those who combine technical excellence with strategic agility and stakeholder engagement.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Animal Growth Promoters Market, by Product Type

  • 8.1. Antibiotics
    • 8.1.1. Aminoglycosides
    • 8.1.2. Macrolides
    • 8.1.3. Penicillins
    • 8.1.4. Tetracyclines
  • 8.2. Enzymes
    • 8.2.1. Carbohydrase
    • 8.2.2. Phytase
    • 8.2.3. Protease
  • 8.3. Hormones
    • 8.3.1. Androgens
    • 8.3.2. Estrogens
    • 8.3.3. Progesterones
    • 8.3.4. Somatotropins
  • 8.4. Ionophores
  • 8.5. Phytogenics
    • 8.5.1. Essential Oils
    • 8.5.2. Herbal Extracts
    • 8.5.3. Spices
  • 8.6. Prebiotics
    • 8.6.1. Fructo Oligosaccharides
    • 8.6.2. Galacto Oligosaccharides
    • 8.6.3. Mannan Oligosaccharides
  • 8.7. Probiotics
    • 8.7.1. Bacillus
    • 8.7.2. Bifidobacterium
    • 8.7.3. Lactobacillus

9. Animal Growth Promoters Market, by Animal Type

  • 9.1. Aquatic Animals
  • 9.2. Cattle
  • 9.3. Poultry
  • 9.4. Swine

10. Animal Growth Promoters Market, by Form

  • 10.1. Granules
  • 10.2. Liquid
  • 10.3. Pellets
  • 10.4. Powder

11. Animal Growth Promoters Market, by Mode Of Administration

  • 11.1. Feed Additive
  • 11.2. Injectable
  • 11.3. Water Additive

12. Animal Growth Promoters Market, by Application

  • 12.1. Disease Prevention
  • 12.2. Growth Promotion
  • 12.3. Reproduction

13. Animal Growth Promoters Market, by Distribution Channel

  • 13.1. Online
  • 13.2. Offline

14. Animal Growth Promoters Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Animal Growth Promoters Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Animal Growth Promoters Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Animal Growth Promoters Market

18. China Animal Growth Promoters Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Alltech, Inc.
  • 19.6. Anpario plc
  • 19.7. Archer Daniels Midland Company
  • 19.8. Bayer AG
  • 19.9. Biomin Holding GmbH
  • 19.10. Boehringer Ingelheim Animal Health USA Inc.
  • 19.11. Cargill, Incorporated
  • 19.12. Ceva Sante Animale
  • 19.13. Chr. Hansen Holding A/S
  • 19.14. DSM-Firmenich AG
  • 19.15. Elanco Animal Health Incorporated
  • 19.16. Hubbard Feeds, Inc.
  • 19.17. Kemin Industries, Inc.
  • 19.18. Kent Nutrition Group, Inc.
  • 19.19. Lallemand Animal Nutrition
  • 19.20. Merck & Co., Inc.
  • 19.21. Nutreco N.V.
  • 19.22. Phibro Animal Health Corporation
  • 19.23. Purina Animal Nutrition LLC
  • 19.24. Vetoquinol S.A.
  • 19.25. Virbac SA
  • 19.26. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ANIMAL GROWTH PROMOTERS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES ANIMAL GROWTH PROMOTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA ANIMAL GROWTH PROMOTERS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY AMINOGLYCOSIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY AMINOGLYCOSIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MACROLIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MACROLIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PENICILLINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PENICILLINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PENICILLINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY TETRACYCLINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY TETRACYCLINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY CARBOHYDRASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY CARBOHYDRASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY CARBOHYDRASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROTEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROTEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROTEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANDROGENS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANDROGENS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANDROGENS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ESTROGENS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ESTROGENS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ESTROGENS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROGESTERONES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROGESTERONES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROGESTERONES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SOMATOTROPINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SOMATOTROPINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SOMATOTROPINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY IONOPHORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY IONOPHORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY IONOPHORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ESSENTIAL OILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ESSENTIAL OILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ESSENTIAL OILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HERBAL EXTRACTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HERBAL EXTRACTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HERBAL EXTRACTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SPICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SPICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SPICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FRUCTO OLIGOSACCHARIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FRUCTO OLIGOSACCHARIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FRUCTO OLIGOSACCHARIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GALACTO OLIGOSACCHARIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GALACTO OLIGOSACCHARIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GALACTO OLIGOSACCHARIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MANNAN OLIGOSACCHARIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MANNAN OLIGOSACCHARIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MANNAN OLIGOSACCHARIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY BACILLUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY BACILLUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY BACILLUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY BIFIDOBACTERIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY BIFIDOBACTERIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY BIFIDOBACTERIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY LACTOBACILLUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY LACTOBACILLUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY LACTOBACILLUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY AQUATIC ANIMALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY AQUATIC ANIMALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY AQUATIC ANIMALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY POULTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY POULTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SWINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SWINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GRANULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GRANULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GRANULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PELLETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PELLETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PELLETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FEED ADDITIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FEED ADDITIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FEED ADDITIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY WATER ADDITIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY WATER ADDITIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY WATER ADDITIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISEASE PREVENTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISEASE PREVENTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISEASE PREVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GROWTH PROMOTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GROWTH PROMOTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GROWTH PROMOTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY REPRODUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY REPRODUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY REPRODUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 149. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, 2018-2032 (USD MILLION)
  • TABLE 150. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 151. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 152. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 154. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 155. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE ANIMAL GROWTH PROMOTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST ANIMAL GROWTH PROMOTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC ANIMAL GROWTH PROMOTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 248. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN ANIMAL GROWTH PROMOTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 262. GCC ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 263. GCC ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. GCC ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 265. GCC ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 266. GCC ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 267. GCC ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, 2018-2032 (USD MILLION)
  • TABLE 268. GCC ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 269. GCC ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 270. GCC ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. GCC ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 272. GCC ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 273. GCC ANIMAL GROWTH PROMOTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 274. GCC ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPEAN UNION ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPEAN UNION ANIMAL GROWTH PROMOTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 293. BRICS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 296. BRICS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 297. BRICS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 298. BRICS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 299. BRICS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 300. BRICS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 301. G7 ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 302. G7 ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 303. G7 ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 304. G7 ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 305. G7 ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 306. G7 ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, 2018-2032 (USD MILLION)
  • TABLE 307. G7 ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 308. G7 ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 309. G7 ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 310. G7 ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 311. G7 ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 312. G7 ANIMAL GROWTH PROMOTERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 313. G7 ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 314. NATO ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 315. NATO ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 316. NATO ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 317. NATO ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
  • TABLE 318. NATO ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, 2018-2032 (USD MILLION)
  • TABLE 319. NATO ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, 2018-2032 (USD MILLION)
  • TABLE 320. NATO ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 321. NATO ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, 2018-2032 (USD MILLION)
  • TABLE 322. NATO ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 323. NATO ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 324. NATO ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 325. NATO ANIMAL GROWTH PROMOTERS MARKET SIZE,